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The primary effector for Shigella invasion of epithelial cells is IpaC, which is secreted via a type III secretion
system. We recently reported that the IpaC N terminus is required for type III secretion and possibly other
functions. In this study, mutagenesis was used to identify an N-terminal secretion signal and to determine the
functional importance of the rest of the IpaC N terminus. The 15 N-terminal amino acids target IpaC for
secretion by Shigella flexneri, and placing additional amino acids at the N terminus does not interfere with IpaC
secretion. Furthermore, amino acid sequences with no relationship to the native IpaC secretion signal can also
direct its secretion. Deletions introduced beyond amino acid 20 have no effect on secretion and do not adversely
affect IpaC function in vivo until they extend beyond residue 50, at which point invasion function is completely
eliminated. Deletions introduced at amino acid 100 and extending toward the N terminus reduce IpaC’s
invasion function but do not eliminate it until they extend to the N-terminal side of residue 80, indicating that
a region from amino acid 50 to 80 is critical for IpaC invasion function. To explore this further, the ability of
an IpaC N-terminal peptide to associate in vitro with its translocon partner IpaB and its chaperone IpgC was
studied. The N-terminal peptide binds tightly to IpaB, but the IpaC central hydrophobic region also appears
to participate in this binding. The N-terminal peptide also associates with the chaperone IpgC and IpaB is
competitive for this interaction. Based on additional biophysical data, we propose that a region between amino
acids 50 and 80 is required for chaperone binding, and that the IpaB binding domain is located downstream
from, and possibly overlapping, this region. From these data, we propose that the secretion signal, chaperone
binding region, and IpaB binding domain are located at the IpaC N terminus and are essential for presentation
of IpaC to host cells during bacterial entry; however, IpaC effector activity may be located elsewhere.
A common theme among many gram-negative bacterial
pathogens is the presence of a type III secretion system
(TTSS), which is composed of 25 to 30 genes that are collec-
tively responsible for transporting effector proteins from the
bacterial cytoplasm to a target host cell membrane and/or
cytoplasm (18). The sequences of the component proteins of
the TTSS apparatus are homologous to those that make up the
gram-negative flagellar basal body (2, 18, 25). Likewise, the
TTSS apparatus outwardly resembles a flagellar basal body
with the filament replaced by a needle that serves as a channel
for the movement of effectors out of the bacterial cytoplasm
following contact with a target cell (5, 7). Prior to transport,
most TTSS effector proteins are translated and held in the
bacterial cytoplasm by their cognate chaperones (2). Following
host cell contact, however, there is a release of the effectors
from their chaperones and a temporal transport of these pro-
teins to the host cell via the TTSS needle (7, 18, 23). Some of
the TTSS effectors are inserted into the host cell membrane to
form a conduit (translocon), which helps in the subsequent
movement of other effectors into the host cytoplasm (5, 8, 33,
37). Most TTSS effectors that gain access to the host cytoplasm
function in promoting cytoskeletal rearrangements and/or sub-
verting host cell signaling processes (1, 13, 14, 18, 32, 43).
Although TTSS structural components from diverse gram-
negative pathogens share significant sequence and structural
similarities, the sequences and functions of the protein sub-
strates targeted for TTSS export are quite diverse. In contrast,
the organization of important functional regions within the
primary structures of these effectors does appear to be con-
served (18). Within the first 25 amino acids lies a sequence or
structural component necessary for effector protein secretion
(20). The amino acid sequence of this region varies greatly, not
only between proteins from different organisms, but also be-
tween TTSS substrates within a single organism (18). Never-
theless, deletion of this region or mutations in the region
expected to cause substantial changes in the biophysical char-
acteristics of the region abolishes substrate secretion (20, 21).
Downstream from the TTSS export signal lies a structure often
referred to as a translocation region (18). Deletion of this
region does not adversely affect secretion of the substrate, but
it does abolish proper transport of the protein to the host cell.
Though not located at a specific site, many TTSS substrates,
especially those that are inserted into the host cell membrane
to form the translocon, also have a hydrophobic segment hav-
ing predicted transmembrane segments, along with predicted
coiled-coil structures (8, 29). The most diverse component of
TTSS effector substrates is the nature of the effector function
itself, which is often located within the C-terminal half of the
protein (18).
For Shigella flexneri, the TTSS and its substrates are required
for invasion of human colonic epithelial cells, an early step in
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the development of bacillary dysentery (39). Enterocyte inva-
sion is governed by a subset of proteins encoded by the mxi,
spa, and ipa loci located within a 31-kb region of a large
virulence plasmid (35). The mxi/spa operons encode the TTSS
apparatus composed of a cytoplasmic bulb, a transmembrane
neck domain, and an external needle (5, 7). The ipa operon
encodes the effectors, IpaA, B, C, and D, along with IpgC, the
cognate chaperone for IpaB and IpaC (39). IpaB and IpaC are
stored within the bacterial cytoplasm and are prevented from
forming a complex by interactions with IpgC (23). Following
host cell contact by the needle complex of the Shigella TTSS,
cytoplasmic IpaB and IpaC are transported through the needle
complex and inserted into the host cell membrane to form a
2.5-nm pore through which other protein effectors are believed
to pass (5). Interaction of the Ipa proteins at the host-pathogen
interface leads to localized actin polymerization on the inner
face of the host membrane. Activation of Cdc42 causes the
formation of filopodia that mature into lamellopodia and even-
tually trap the bacterium in a membrane-bound vacuole (40).
Following entry, the vacuolar membrane is lysed and the bac-
terium enters the host cell cytoplasm to replicate and directly
invade neighboring cells (3, 34). While both IpaB and IpaC
have been implicated as effectors for subverting host cell sig-
naling events, IpaC possesses biochemical properties that are
consistent with its having a major role in triggering S. flexneri
entry into host cells. IpaC does not have a specific cellular
receptor, but it does associate with phospholipid membranes
(11, 38), trigger dramatic cytoskeletal changes in cultured cells
(22, 40), form homopolymers (10, 27), and oligomerize with
IpaB to form membrane pores (5, 27, 30).
Much of what is known about the structural components
necessary for proper translocation of TTSS substrates has been
elucidated in Yersinia species (6, 18). Meanwhile, the determi-
nants needed for movement of TTSS targets into host cells by
pathogens like S. flexneri remain unknown except by extrapo-
lation and conjecture. With respect to IpaC, it has been shown
recently that the N terminus is responsible for proper secretion
and translocation, while the C terminus probably possesses
effector functions (30). Using a yeast two-hybrid system, Page
and colleagues suggested that IpgC interacts with a region near
the N terminus of IpaC and of IpaB and that IpaC interacts
with the C terminus of IpaB (28). The region of IpaC that
interacts with IpaB remains unknown.
The use of Shigella to determine the molecular basis for the
secretion of TTSS substrates is attractive because of the rela-
tive simplicity of this pathogen’s invasion mechanism. Unlike
Salmonella, Shigella possesses only one known TTSS (18), and
IpaC appears to be the only Shigella effector molecule required
for the up-regulation of Rho subfamily GTPases (39). Further-
more, IpaC and the related Salmonella invasion protein SipC
are presently the only known translocon proteins that also have
recognized effector functions (16, 39). It has been demon-
strated previously that deletion of a large segment from the
IpaC N terminus eliminates its ability to function as a TTSS
substrate (30). In the work presented here, the IpaC N termi-
nus is further dissected to identify the precise region needed
for Shigella TTSS-dependent export, the region needed for
IpaC binding to its cognate chaperone, and the region or re-
gions involved in IpaB binding.
MATERIALS AND METHODS
Materials. S. flexneri 2a strain 2457T was grown at 37°C on Trypticase soy agar
containing 0.025% Congo red. The S. flexneri ipaC mutant strain SF621 was from
P. J. Sansonetti (Unite de Pathogenie Microbienne Moleculaire, Institut Pas-
teur) (24). IpaC monoclonal antibodies were from E. V. Oaks (Department of
Enteric Infections, Walter Reed Army Institute for Research) (41). Henle 407
cells (ATCC CCL6) were propagated as monolayers in Eagle’s modified minimal
essential medium (MEM) (Fisher Scientific, St. Louis, Mo.) supplemented with
10% newborn calf serum (Life Technologies, Gaithersburg, Md.) and grown in
5% CO2. PCR SuperMix High Fidelity and oligonucleotides were from Invitro-
gen (Carlsbad, Calif.), and NovaBlue and BL21(DE3) strains of Escherichia coli
pET15b were from Novagen (Madison, Wis.). Fluorescein isothiocyanate
(FITC), fluorescein maleimide (FM), 3-[4-(isothiocyanato)-7-diethylamino-4-
methylcoumarin (CPI), and 5-((((2-iodoacetyl)amino)ethyl) amino) naphtha-
lene-1-sulfonic acid (IAEDANS) were from Molecular Probes, Inc. (Eugene,
Oreg.). All other chemicals were reagent grade.
Generation of ipaC deletion mutants for expression in S. flexneri SF621. The
preparation of pWPsf and pWPsfc has been described in detail (30). pWPsfc was
the original construct generated in this laboratory for expressing ipaC in S.
flexneri SF621; however, IpaC synthesized from pWPsfc possesses eight addi-
tional amino acids from -galactosidase (MTMITNSH) at its immediate N
terminus. Even though these amino acids do not interfere with the ability of IpaC
to restore invasiveness to SF621, pWPsf4c was designed to allow translation to
begin with the first Met codon of the actual ipaC insert (see Table 1). Further-
more, the ipaC coding sequence used in pWPsfc is based on the DNA sequence
reported by Venkatesan and coworkers (42), which actually encodes a protein
that is 19 amino acids longer than the actual native form of IpaC. These residues
(designated residues 19 to 1) are shown in italics in Table 1. pWPsfc’ and
pWPsf4c’ (with and without the eight -galactosidase residues, respectively)
were designed to allow the synthesis of IpaC lacking the residues 19 to 1.
ipaC deletion mutants were made by inverse PCR by using pWPsfc or pWPsf4c
(or their c’ counterparts) as template and primers encoding GAGAGA, an XhoI
or NdeI restriction site, and 18 nucleotides flanking the region to be deleted. The
desired linear plasmid was amplified by PCR, digested with NdeI or XhoI,
intramolecularly ligated, and transformed into E. coli NovaBlue. The resulting
plasmid was introduced into S. flexneri SF621 by electroporation. Ampicillin
selection ensured the presence of the recombinant plasmid, while kanamycin
resistance and/or Congo red binding was used to ensure that the transformants
still possessed the S. flexneri virulence plasmid. The changes introduced at the
IpaC N terminus and the plasmids used to generate these IpaC mutants in S.
flexneri SF621 are described in Table 1, which also describes the relative level of
secretion and invasion by S. flexneri SF621 for each of the resulting IpaC deriv-
atives.
Generation of ipaC/sipC chimeras for expression in S. flexneri SF621. SipC/
IpaC chimeric proteins were generated by amplifying specific sipC fragments by
using a 5 primer containing GAGAGA, an NdeI site, and 18 bases of sipC coding
sequence. The 3 primer contained GAGAGA, an XhoI site, and 18 bases
upstream corresponding to the 3 end of the sipC fragment being generated.
These fragments were ligated with ipaC fragments designed to have XhoI sites at
their 5 ends. After insertion of the chimeric sipC/ipaC gene into pWPsf, S.
flexneri SF621 was transformed for synthesis of the resulting chimeric proteins.
The chimeras used in this experiment were IpaC19-62/SipC82-409, IpaC19-177/
SipC197-409, SipC1-81/IpaC63-363, and SipC1-189/IpaC171-363.
Preparation of affinity-purified recombinant proteins. Plasmids used to pre-
pare recombinant IpaC (called IpaC19-363 here), IpaC9-62 (IpaCI), IpaB,
SipC, and SipB have been previously described (22, 27, 30, 31). pWP2916 (for
generating IpaC21-100) was prepared by subcloning the mutant ipaC gene from
pWPsf2916C into pET15b. pWPC171-363 (lacking residues 19 to 170) was gen-
erated as described for pWPC15, except that the 5 primer was designed to start
ipaC translation at codon 171. pWPI’ was designed to encode an IpaC peptide
called region I (IpaC19-100), which consists of amino acids 19 to 100. This
plasmid was generated as described for pWPC15 except that the 3 primer was
designed to place a translation stop site at codon position 101. pWPipgC was
produced in the same way as pWPC15 by copying the gene from the virulence
plasmid of Shigella by using a 5 primer containing an XhoI restriction site and a
3 primer containing a BamHI site. All new plasmids were transformed into E.
coli BL21(DE3) for high levels of protein production. Recombinant proteins
were purified via the N-terminal His6 tag by nickel chelation chromatography as
described in detail previously (31).
For some fluorescence analyses, an IpaC derivative was generated that con-
sisted of amino acids 51 to 362 with Met and Cys residues at the immediate N
terminus. The gene encoding this protein, called IpaCCys, was produced by
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inverse PCR by using a primer that contained GAGAGA, an XhoI restriction
site, the TGC Cys anticodon, the NdeI restriction site, and 10 bases of the
pET15b vector upstream from the NdeI site. The second primer contained
GAGAGA, an XhoI restriction site, and 18 bases from IpaC starting at codon 51.
The PCR fragment was digested with XhoI, intramolecularly ligated, and trans-
formed into E. coli NovaBlue cells. The resulting plasmid was purified and used
to transform E. coli BL21(DE3) to synthesize protein that could be affinity
purified via an N-terminal His6 tag.
Assay of bacterial entry into cultured epithelial cells. S. flexneri invasion of
Henle 407 cells was monitored by using a standard gentamicin protection assay
as described previously (10). Preconfluent monolayers of Henle 407 cells were
seeded into 24-well plates and grown overnight. SF621 harboring the desired
plasmid was grown in Trypticase soy broth containing 100 g of ampicillin/ml
and 50 g of kanamycin/ml to an A600 of 0.4 to 0.6. The bacteria were then
diluted with serum-free MEM containing 0.45% glucose (MEM-glc), centrifuged
onto the surface of semiconfluent Henle 407 monolayers, and incubated with the
cells for 30 min at 37°C. Free bacteria were removed by aspiration, and the cells
were washed with MEM containing 5% calf serum and 50 g of gentamicin/ml.
The cells were incubated in the final gentamicin wash for 2 h to kill adherent,
noninternalized bacteria and rinsed with MEM-glc. The cells were lysed by
overlaying them with 250 l of 0.5% agarose in water. The agarose was then
overlaid with 0.5% agar containing 2 Luria-Bertani medium. After overnight
incubation at 37°C, internalized bacteria formed subsurface colonies that were
quantified.
Measurement of IpaC secretion by ELISA. Bacteria were grown to an A600 of
0.5 to 0.8, and 10 ml of the culture was centrifuged for 10 min at 4,500  g. The
bacterial pellet was resuspended in 400 l of carbonate buffer, and the cells were
lysed by sonication to release cytoplasmic IpaC antigen. The culture supernatant
was the source of secreted IpaC antigen. Each antigen source was diluted 1:3
with carbonate buffer, and 100 l was used to coat the wells of a polystyrene
96-well microtiter plate that was incubated overnight in preparation for a stan-
dard enzyme-linked immunosorbent assay (ELISA).
Fluorescence labeling of proteins. Recombinant IpaC and its derivatives were
labeled at primary amines by using FITC. Briefly, the purified proteins were
dialyzed against 0.1 M carbonate (pH 8.0) containing 2 M urea and labeled with
FITC by combining 1/10 volume of 1 mg of FITC/ml in DMF with 1 ml of
protein. The concentration of protein used for fluorescence labeling varied
somewhat from one preparation to the next, but it was always maintained be-
tween 1 and 2 mg/ml in the reaction mixture. After incubating at 4°C, the labeled
protein was separated from unreacted dye by gel filtration on Sephadex G25
equilibrated with Tris-buffered saline containing 1 M urea. The fluorescent
protein was rapidly diluted in Tris-buffered saline lacking urea to promote
folding into its final tertiary structure. The FITC labeling efficiency for each IpaC
derivative was between 2 and 3 probes per protein based on an FITC extinction
coefficient of 70,000 at 490 nm. IpaC region I’ was also labeled with CPI by using
the same protocol except that the dye concentration was reduced by half and the
reaction mixture was made to 50% DMF. IpgC was labeled with FITC by using
the same reaction conditions used to make FITC-IpaC except without urea, as
IpgC is more soluble in aqueous solutions. FITC-IpgC labeled at a lower stoi-
chiometry than IpaC (0.26 FITC/protein). Alternatively, some IpaC derivatives
were site-specifically labeled at a single Cys residue with FM or IAEDANS in
Tris (pH 7.5)–150 mM NaCl–2 M urea.
Monitoring protein-protein interactions by using fluorescence polarization.
After excitation with polarized light, the photons emitted by fluorescent probes
are also polarized; however, rotational diffusion of a fluorophore over its excited-
state lifetime causes depolarization of the emitted photons (19). Fluorescence
polarization measures the average angular displacement of a fluorophore over its
excited-state lifetime, which is affected by the molecule’s rate of rotational
diffusion, as described by the relationship P  (I  I)/(I  I), where P is the
polarization value (ranging from 0 to 0.5), I is the fluorescence intensity with the
excitation beam polarized vertically and the emission beam polarized in a par-
allel fashion, and I is the fluorescence intensity when the excitation beam is
polarized vertically and the emission beam is polarized in a perpendicular fash-
ion (19). Because the rate of rotational diffusion of a molecule is inversely related
to its size, polarization provides a sensitive measure of changes in molecular
volume that occur when the fluorescent protein is bound by a nonfluorescent
protein (19). Fluorescence polarization was used to monitor the association of
FITC-labeled IpaC (or its recombinant derivatives) with nonfluorescent IpaB.
Polarization was measured by using a Beacon 2000 variable-temperature fluo-
rescence polarization system (PanVera Corp., Madison, Wis.) with a 480-nm
bandpass excitation filter and a 530-nm bandpass emission filter. Samples (0.5 ml
each) were measured at 25°C in a 10- by 75-mm borosilicate glass tube, with three
average cycles read per sample. Polarization values are presented in millipolar-
ization (mP) units.
TABLE 1. Plasmids used in this study and relative levels of secretion and invasion activity of the
resulting IpaC proteins in S. flexneri SF621
Plasmid N-terminal IpaC sequencea Secretion(%)b
Relative
invasionc
pWPsf (and pWPsf4)d No ipaC insert 0 0 	 0
pWPsfc’ MTMITNSHMEIQNTKPTQTLYTDISTKQ 100 100 	 3
pWPsf4c’ MEIQNTKPTQTLYTDISTKQ 100 105 	 4
pWPsf4c’1-20 M 0 0 	 1
pWPsf4c’18-20 MEIQNTKPTQTLYTDISLE 80 76 	 9
pWPsf4c’16-20 MEIQNTKPTQTLYTLE 100 88 	 9
pWPsf4c’11-20 MEIQNTKPTQTLE 20 15 	 6
pWPsf4c’MAIAA MAIAATKPTQTLYTDISTKQ 20 25 	 10
pWPsfc MTMITNSHMLQKQFCNKLLLDTNKENVMEIQNTKPTQTLYTDISTKQ 99 77 	 33
pWPsf4c MLQKQFCNKLLLDTNKENVMEIQNTKPTQTLYTDISTKQ 97 90 	 5
pWPsfc-6-20 MTMITNSHMLQKQFCNKLLLDT 100 85 	 10
pWPsf4c-6-20 MLQKQFCNKLLLDT 0 0 	 1
pWPsf4c-6-20HIT MHQIQTCNKLLLDT 100 100 	 15
pWPsf4c’1-20ipaD MNITTLTNSISTSSLE 100 n.d.
pWPsf4c’1-20ipaB MHNVSTTTTGFPLALE 75 n.d.
pWPsf4c’1-20ipaA MHNVNNTQADTFLYLE 100 n.d.
pWPsf4c’1-20ipgD MHITNLGLHQVSFQLE 100 n.d.
a The sequences shown are all the amino acids preceding what would be residue 21 of native IpaC. The remainder of the protein (amino acids 21 to 363) is not
changed. Boldfaced amino acid sequences are native IpaC sequences; italicized amino acids are residues 19 to 1 of IpaC19-363, which were originally described
as representing the first 19 amino acids of native IpaC according to the DNA sequence data reported by Venkatesan and colleagues (42). Underlined amino acids are
the eight -galactosidase residues added to the N terminus when IpaC is generated from the plasmid pWPsf; normal text represents either amino acid substitutions
in the native IpaC secretion signal or amino acids derived from other S. flexneri TTSS substrates used to replace amino acids 1 to 20 of IpaC.
b Secretion of IpaC into culture supernatants was determined by ELISA by using monoclonal antibodies specific for sequences located in the C-terminal half of IpaC.
The values shown are normalized for the secretion level of IpaC19-363. The values given are averages of triplicate results, with an error of less than 10% in all cases.
c Invasion of Henle 407 cells is shown relative to S. flexneri SF621 harboring pWPsfc’, as described in Materials and Methods. The invasion efficiency of IpaC
possessing residues from other TTSS substrates at its N terminus was not determined (n.d.).
d These plasmids are the backbones into which the ipaC coding sequence was inserted. Insertion of ipaC coding sequences into pWPsf results in the production of
an IpaC protein possessing eight additional -galactosidease residues (MTMITNSH), while insertion into pWPsf4 results in production of an IpaC protein with no
-galactosidase residues at the N terminus.
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Monitoring the effect of IpaB and IpgC binding on the solvent accessibility of
site-specific probes on IpaC by using fluorescence quenching analysis. Steady-
state fluorescence quenching was used to determine solute accessibility to an FM
probe linked to the single Cys residue (position 13) of IpaC19-363 or the Cys
at position 2 of IpaCCys in the presence and absence of IpaB or IpgC. The
association of either nonfluorescent protein near the label would be expected to
shield the site-specific fluorescent probe from interaction with solute molecules
such as acrylamide, which quenches FM fluorescence according to the relation-
ship first described by Stern and Volmer (36) and modified by Eftink (12). To
quantify quenching, the emission spectrum of the sample was taken in the
absence and then the presence of increasing concentrations of acrylamide. A
graph of Fo/F versus acrylamide concentration was then plotted where Fo is the
starting fluorescence intensity and F is the observed intensity at a given concen-
tration of acrylamide. The Stern-Volmer steady-state quenching constant (Ksv) is
given by the slope of this plot according to the relationship Fo/F  1  Ksv[Q],
where [Q] is the concentration of acrylamide in the sample. The larger the Ksv
value, the greater accessibility acrylamide has to the fluorescent probe.
Monitoring the relationship between IpgC and IpaB binding to region I’
(IpaC19-100) by using energy transfer. Another method for sensitively detecting
protein-protein interactions is fluorescence resonance energy transfer (FRET),
as described by Lakowicz (19). For FRET, region I’ (IpaC19-100) was labeled
with a coumarin donor probe, CPI, while a second protein was labeled with a
fluorescein acceptor probe, FITC. The donor probe is one whose emission
spectrum overlaps the absorption spectrum of the acceptor probe. This property
allows nonradiative transfer of donor excitation energy to the acceptor in a
distance-sensitive manner. FRET efficiency depends on the degree of overlap of
donor emission and acceptor absorption and their relative dipole orientations.
These properties provide a characteristic Ro distance (giving 50% FRET effi-
ciency) for different donor-acceptor pairs (19). More importantly, for distances
less or greater than Ro, energy transfer efficiency changes by an inverse sixth
power relationship, making FRET extremely useful for monitoring the approach
of one macromolecule to another (19). The coumarin protein used here serves as
a donor for pairing with fluorescein-labeled Ipa protein acceptors (Ro, near 4.5
nm).
To determine FRET from CPI-I’ to FITC-IpgC, a set concentration of CPI-I’
was mixed with either a known concentration of FITC-IpgC (FDa) or the same
concentration of unlabeled IpgC (Fd). A fluorescence emission spectrum was
then collected on a FluoroMax spectrofluorometer (JY/Spex, Edison, N.J.) by
using an excitation wavelength of 385 nm with emission scanned from 430 to 500
nm. FRET efficiency was then determined from the relationship E  1 
(FDa/Fd). The advantage of using FRET analysis over fluorescence polarization
in this case is that additional nonfluorescent proteins can be added to determine
whether they are competitive for the observed binding event. In this case, non-
fluorescent IpaB was used as a potential competitor for the association between
region I’ and IpgC. In other experiments, FRET was used to monitor the
distance from an IAEDANS bound to Cys-13 of IpaC19-363 or the N-terminal
Cys of IpaCCys to FITC-IpgC.
Measurement of contact-mediated hemolysis. Contact-mediated hemolysis
was measured as described by Sansonetti (34). Briefly, S. flexneri were grown
overnight on Trypticase soy agar-Congo red plates, and a single red colony was
used to inoculate Trypticase soy broth. The bacteria were grown to mid-log
phase, and the cells were collected by centrifugation and resuspended in phos-
phate-buffered saline (PBS) at 1/40 of the original volume. Sheep red blood cells
were washed and resuspended in PBS at a concentration of 1  1010 cells/ml.
Red blood cells and bacteria (50 l of each) were added to wells of microtiter
plates, and the plates were centrifuged at 2,200  g for 15 min at 20°C. The plates
were then incubated at 37°C for 2 h. The cells were resuspended by adding 90 l
of cold PBS, and the plates were centrifuged again at 2,200  g at 15°C for 15
min. The supernatant fraction (100 l) was transferred to a second microtiter
plate, and the absorbance of the released hemoglobin was measured by absor-
bance by using a microtiter plate reader.
RESULTS
Identifying the minimum sequence needed at the IpaC N
terminus for secretion. Consistent with TTSS substrates from
other systems (18), deletion of the first 20 amino acids of IpaC
abolishes its ability to be secreted into S. flexneri culture su-
pernatants (see Table 1). The absence of secretion is reflected
in the loss of IpaC’s ability to restore invasiveness to the ipaC
mutant S. flexneri SF621 (Table 1). In contrast, deletion of
amino acids 21 to 50 did not adversely affect IpaC secretion
(data not shown), invasiveness, or contact hemolysis activity
(Table 2). To determine the minimum number of amino acids
needed for efficient IpaC secretion, different deletions were
introduced that ended at amino acid 20 (Table 1). Deleting
amino acids 18 to 20 (replacing TKQ with LE of the XhoI
restriction site; see Materials and Methods) had only a minor
effect on IpaC secretion, and deletion of residues 15 to 20 had
even less effect on IpaC secretion. In contrast, deletion of
amino acids 12 to 20 resulted in an 80% reduction in IpaC
secretion from SF621 (Table 1), indicating that the informa-
tion needed for IpaC secretion lies within the first 15 amino
acids.
Identification of amino acids important to IpaC secretion.
Recently, it was shown that replacing the secretion signal of
YopE from Yersinia enterocolitica with an amphipathic peptide
consisting of alternating Ser and Ile restored the protein’s
secretion function (20, 21). Those data suggest that there is a
structural feature at the N terminus of YopE, rather than a
specific amino acid sequence, that is needed to trigger type III
secretion. However, when the first 20 amino acids of IpaC were
replaced with a 15-amino-acid poly(I-S) sequence, secretion
and invasion functions were not restored to IpaC (data not
shown). Because the N terminus of IpaC, unlike that of YopE,
contains several charged amino acids, the first three polar
residues of IpaC were replaced with Ala (1MEIQN5 3
1MAIAA5). In this case, IpaC secretion was reduced 80%,
which was accompanied by a nearly 80% decrease in invasion
function (Table 1), showing that amino acids that disrupt the
physical and/or chemical properties of the IpaC N terminus
eliminate a feature necessary for IpaC secretion. Individual
Ala replacements for these three polar residues had no nega-
tive effect on IpaC secretion (data not shown).
This laboratory was the first to purify recombinant IpaC for
biochemical analysis (22, 31); however, it was originally cloned
based on the sequence reported by Venkatesan (42), which
encodes a protein that is 19 amino acids longer than native
IpaC. Thus, the recombinant protein consisted of amino acids
19 to 363 (IpaC19-363) based on the numbering system of
Turbyfill (41). For expression in the nonpolar ipaC mutant S.
flexneri SF621, ipaC9-363 was inserted into the modified
pUC18 plasmid pWPsf. The resulting plasmid construct








None 0 	 0 8 	 2
ipaC 100 	 10 100 	 5
ipaC21-50 100 	 5 100 	 10
ipaC21-55 5 	 1 10 	 2
ipaC63-100 5 	 1 12 	 6
ipaC81-100 25 	 5 85 	 5
ipaC92-100 75 	 8 70 	 10
a Invasion of Henle 407 cell monolayers was tested by using a standard gen-
tamicin protection assay, and the values shown are relative to that of SF621
expressing the native form of ipaC. Bacteria were added to monolayers at a
multiplicity of infection of approximately 50.
b The values shown for the contact hemolysis assay are the percent lysis of
sheep red blood cells relative to that with the addition of water, which causes
complete hemolysis.
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(pWPsfc) also led to the addition of eight lacZ codons at the 5
end of ipaC9-363 (Table 1). The resulting IpaC derivative
restored invasiveness and contact hemolysis activity (data not
shown) to SF621, demonstrating that additions at the N ter-
minus do not interfere with IpaC function. Introduction of
ipaC9-363 into the plasmid pWPsf4 eliminates the extra eight
lacZ codons (Table 1). As expected, pWPsf4c encodes an
IpaC19-363 derivative that is also secreted and restores inva-
siveness to SF621. In contrast, deletion of amino acids 6 to 20
(pWPsf4c-6-20) eliminates the putative secretion signal and
abolishes IpaC secretion. However, when this ipaC sequence is
subcloned into pWPsf (pWPsfc-6-20), thereby introducing
the eight LacZ residues at the IpaC N terminus, IpaC is once
again secreted by SF621 and invasiveness is restored (Table 1).
More intriguing is the fact that if the first six amino acids of
pWPsf4c-6-20 are changed from MLQKQF to MHQIQT,
secretion is restored to 100% of that seen for native IpaC. As
in Yersinia spp., none of these constructs allows identification
of a consensus secretion sequence, suggesting that there is no
consensus sequence for the secretion but that instead, a struc-
tural feature is responsible for signaling export. This concept is
supported by four constructs in which the first 20 amino acids
encoded by pWPsf4c’ are replaced by the first 14 amino acids
of IpaA, IpaB, IpaD, and IpgD. All four of these constructs
encode an IpaC chimera that is efficiently secreted, with only
the IpaB chimera being secreted to a lesser extent (Table 1).
Identification of an important functional region near the N
terminus of IpaC. Small deletions beyond amino acid 20 do not
adversely affect IpaC’s ability to restore invasiveness to S. flex-
neri SF621 (Table 2). However, when these deletions extend
beyond amino acid 50, they immediately eliminate IpaC inva-
sion and contact hemolysis functions in vivo (Table 2) without
affecting secretion (data not shown). From these data, a region
essential to IpaC activity is believed to have a sharp N-terminal
boundary between amino acids 50 and 55. To determine the
C-terminal boundary of this essential internal region, deletions
were introduced at amino acid 100 that extended upstream.
When amino acids 92 to 100 were deleted from IpaC, there was
a relatively minor negative effect on function (Table 2). Dele-
tion of amino acids 81 to 100 still did not completely eliminate
IpaC function, but IpaC63-100 was almost completely inactive
in vivo for both invasion and contact hemolysis functions, yet it
was still efficiently secreted (data not shown). These findings
indicate that the region between amino acids 50 and 80 is
essential for IpaC function in S. flexneri. The location of this
region is consistent with that of the chaperone-binding domain
described by Page et al. (28). It may also be required for
association with IpaB within the host cell cytoplasmic mem-
brane.
IpgC binds near the N terminus of IpaC. IpgC is a Shigella
cytoplasmic chaperone that binds to both IpaB and IpaC to
prevent their premature association in the bacterial cytoplasm
(23) and to queue them for secretion. By using fluorescence
polarization, the interaction between IpgC and IpaC19-363
that is site-specifically labeled with thiol-reactive FM at Cys13
can be demonstrated in vitro, with half-maximal binding oc-
curring near 45 nM (Fig. 1). This binding can be localized to
the N terminus of IpaC, since this interaction still occurs for
region I’ (IpaC19-100) labeled with FITC, with a dissociation
constant of about 36 nM (Fig. 1). Furthermore, it seems likely
that the region of IpaC involved in IpgC binding requires the
region between amino acids 50 and 80, based on deletion
mutagenesis data (Table 2) and the fact that a truncated form
of IpaC which consists of amino acids 50 to 363 possesses a
MetCys pair at its immediate N terminus (IpaCCys) and is
labeled with FM binds very tightly to IpgC (Fig. 1). Moreover,
the magnitude of the polarization changes presented in Fig. 1
are consistent with IpgC binding relatively close to the site-
specific FM probe on IpaCCys. In contrast, IpaC9-62 does not
appear to bind IpgC nearly as well (half-maximal binding at
320 nM IpgC) as those IpaC derivatives that possess an intact
region between amino acids 50 and 80 (Fig. 1).
In a related experiment, IpaC19-363 was labeled with
IAEDANS, and the effect of IpgC binding was compared to
that of IAEDANS-labeled IpaCCys. IAEDANS fluorescence is
very sensitive to changes in the probe’s microenvironment (26).
Therefore, the approach of a protein to a site labeled with
IAEDANS should cause a change in the fluorescence proper-
ties of this probe. When the emission maximum and intensity
of IAEDANS-labeled IpaC19-363 and IpaCCys are compared,
the latter undergoes greater change, indicating that IpgC in-
fluences the IAEDANS microenvironment much more for
IpaCCys (Table 3). This is consistent with the observation that
IAEDANS linked to IpaCCys is more efficient at transferring its
excitation energy to FITC-IpgC than is IAEDANS linked to
position 13 of IpaC19-363 (Table 3).
An N-terminal fragment from IpaC associates with IpaB. It
was previously shown that IpaB and IpaC interact in vitro (10),
and the ability of IpaC region I’ to interact with IpaB by
fluorescence polarization was analyzed. Region I’ (IpaC19-100)
was labeled with FITC (FITC-I’) so that its interaction with
IpaB could be monitored in vitro and compared to the ability
of FITC-labeled IpaC19-363, IpaC21-100, and IpaC171-363 to
interact with nonfluorescent IpaB. As shown in Fig. 2A,
FIG. 1. IpgC associates with a region near the N terminus of IpaC
in vitro. Fluorescence polarization was used to monitor the interaction
between fluorescein-labeled IpaC derviatives and nonfluorescent
IpgC. The increase in polarization caused by the addition of increasing
concentrations of IpgC is shown for FM-labeled IpaC19-363 (F),
FITC-labeled region I’ (IpaC19-100) (E), FM-labeled IpaCCys (Œ), and
FITC-labeled IpaC1-62 (‚). IpaCCys is composed of IpaC50-363 with a
MetCys pair at the immediate N terminus. The fluorescent proteins
were used at approximately 20 nM.
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FITC-I’ and FITC-IpaC19-363 are bound by IpaB, with half-
maximal polarization increases at approximately 15 nM IpaB
in each case. IpaC21-100 also associates with IpaB, with the
half-maximal polarization increase for this binding occurring at
approximately 50 nM IpaB (Fig. 2A). However, IpaC171-363,
which lacks both the IpgC binding domain and the central
hydrophobic region, does not appear to associate with IpaB
(Fig. 2A). These data show that while the entire N-terminal
half of IpaC contributes to the formation of IpaB/IpaC com-
plexes, the N-terminal hydrophilic fragment contains a se-
quence that allows the tightest association between IpaC and
IpaB. As expected, the IpgC-IpaB interaction could also be
demonstrated in vitro by using FITC-labeled IpgC (Fig. 2B).
Unlike the random labeling that occurs with FITC,
IpaC19363 and IpaCCys can be site specifically labeled with
FM. IpaC19-363 possesses a single Cys residue at position
13, and IpaCCys lacks amino acids up to residue 50 but
contains a MetCys pair at the immediate N terminus. Each
protein can be labeled with thiol-reactive FM, and solute ac-
cessibility then can be estimated by using fluorescence quench-
ing analysis with acrylamide as the quenching agent. When
IpaB or IpgC is incubated with FM-IpaC19-363, there is rela-
tively little change in the steady-state Stern-Volmer quenching
constant or Ksv, with all Ksv values being near 0.8 M
1 (Fig.
3A). These data indicate that the interaction of IpaB and IpgC
with FM-IpaC19-363 has little effect on acrylamide accessibil-
ity to the fluorescein probe. In contrast, IpaB binding to FM-
IpaCCys resulted in a 40% decrease in acrylamide accessibility
(Fig. 4B), with the Ksv decreasing from 2.73 M
1 to 1.63 M1.
Similarly, IpgC binding to FM-IpaCCys resulted in a 75% de-
crease in Ksv from 2.73 M
1 to 0.71 M1 (Fig. 4B). These data
indicate that, unlike with the fluorescein probe at position
13, the probe near amino acid 50 is more intimately influ-
enced by IpaB and IpgC binding, again indicating that these
proteins bind to a region of IpaC beginning at amino acid 50,
with IpgC binding closer to amino acid 50 than IpaB.
IpgC and IpaB bind competitively to the N terminus of
IpaC. Region I’ (IpaC19-100) was next labeled with a couma-
rin isothiocyanate derivative, CPI, to give CPI-I’, which was
incubated with purified recombinant IpgC labeled with FITC
(FITC-IpgC). Their association was then detected by using
FRET (see Materials and Methods), as shown in Fig. 4. The
CPI donor probe used here paired with FITC is useful for
monitoring distances of less than 50 Å, meaning that FRET is
detected only if CPI-I’ interacts intimately with FITC-IpgC. As
shown in Fig. 4 and Table 4, mixing CPI-I’ with a one- or
tenfold concentration of FITC-IpgC results in more than 50%
energy transfer. The fact that nearly maximum FRET is
achieved at equimolar concentrations of CPI-I’ and FITC-
IpgC suggests a strong association. The observation of 50%
energy transfer is particularly significant, since IpgC labels with
FITC with a relatively low (
30%) efficiency, which means
that the acceptor probes on FITC-IpgC must be in close prox-
imity to the donor probes to give rise to such high levels of
FRET. When this FRET experiment is modified to include
nonfluorescent IpaB (at a concentration equal to that of CPI-
FIG. 2. IpgC binds to both IpaC and IpaB in vitro. (A) IpaC and
proteins derived from IpaC were purified and labeled with FITC for
fluorescence polarization measurements. The increase in polarization
caused by the addition of increasing concentrations of IpaB is shown
for FITC-labeled IpaC19-363 (E), region I’ (IpaC19-100) (F),
IpaC21-100 (Œ), and IpaC171-363 (‚). The values shown are an average
of three measurements of a single sample and are representative of
multiple (three or more) independent experiments. (B) The increase in
the polarization of FITC-labeled IpgC (20 nM) was monitored follow-
ing the addition of increasing concentrations of nonfluorescent IpaB.










IpaC19-363  1.00 485 n.a.
 1.23 482 20
IpaCCys  1.00 480 n.a.
 1.42 475 26
a IpaCCys is composed of IpaC50-363 with a Met-Cys pair at the immediate N
terminus.
b , nonfluorescent IpgC (100 nM) was added to approximately 50 nM
IAEDANS-labeled protein in the absence of any other proteins; , IpgC was not
added.
c Fluorescence intensity is shown relative to that of IAEDANS-labeled protein
in the absence of added IpgC. The intensity of labeled IpaCCys relative to that of
IpaC19-363 was 0.87, indicating that the starting microenvironments of the two
probes are different.
d The wavelength at which the peak of fluorescence occurred was determined
in the presence and absence of nonfluorescent IpaC.
e FRET efficiency was determined by using IAEDANS-labeled protein with
nonfluorescent IpgC to determine Fd and by using IAEDANS-labeled protein
with FITC-IpgC (in the absence of additional nonfluorescent IpgC) to determine
Fda. n.a., not applicable.
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I’), the increase in the level of energy transfer to FITC-IpgC is
almost completely eliminated (Fig. 4). The fact that the IpaC-
IpaB interaction is stronger than the IpgC interaction with
IpaB or IpaC indicates that the decrease in FRET is due to
competition between IpaB and FITC-IpgC for association with
CPI-I’ and not to IpaB simply stripping the IpgC away from
this IpaC fragment. This competition could be partially re-
lieved with the addition of a tenfold greater concentration of
FITC-IpgC (Table 4), showing that IpaB and IpgC are com-
petitive for interactions with region I’.
The N terminus of IpaC can be replaced by the N terminus
of Salmonella SipC. SipC, the Salmonella homologue of IpaC,
is efficiently secreted by S. flexneri but is incapable of replacing
IpaC in restoring invasiveness to SF621 (27), and the portion
of SipC corresponding to the IpaC region displays significant
sequence divergence. Interestingly, polarization experiments
show that FITC-labeled SipC binds IpaB with a half-maximal
polarization change that is similar to that of IpaC21-100 (Table
5), and this IpaC mutant is also incapable of restoring inva-
siveness to SF621. Furthermore, FITC-labeled IpaC binds to
IpaB and Salmonella SipB with what appear to be similar
affinities, and ipaC does restore invasiveness to both S. flexneri
SF621 and the Salmonella sipC mutant SB220. Meanwhile,
FITC-labeled SipC binds to SipB with an affinity that is similar
to that seen for IpaC binding to either IpaB or SipB (Table 5).
These data indicate that differences in IpaC and SipC function
FIG. 3. Association of IpaB and IpgC to FM-IpaCCys results in
protection of the probe from solute quenching. (A) The addition of
increasing concentrations of acrylamide results in quenching of FM-
IpaC19-100 fluorescence (F). The degree of acrylamide quenching is
not greatly affected by the addition of IpaB (E) or IpgC (Œ). The
fluorescent protein was used at 30 nM in each case, and the results are
from a single representative experiment. Acrylamide quenching of
FM-IpaCCys alone is shown by the closed circles, and quenching with
IpgC is shown by the closed triangles. (B) The same experiment was
carried out with FM-IpaCCys at approximately 30 nM. The data shown
are from a single representative experiment. The average Ksv value in
each case (n  3) is given in the text.
FIG. 4. Region I’ (IpaC19-100) associates with IpgC and IpaB in a
competitive manner. (A) The emission spectrum of 230 nM CPI-
labeled region I’ is shown in the presence of an equimolar amount of
IpgC (dashed line) or FITC-labeled IpgC (solid line). The decrease in
emission with FITC-IpgC is due to FRET of CPI excitation energy
from the coumarin to the fluorescein moiety. (B) The same experiment
was carried out with CPI-labeled region I’ and IpgC (dashed line) and
FITC-labeled IpgC (solid line), except that 250 nM IpaB is also
present in the sample. CPI fluorescence was measured by using an
excitation wavelength of 385 nM. The data are from a single repre-
sentative experiment, which was performed three times.








230 nM 0 52
2.3 M 0 53
230 nM 250 5
2.3 M 250 27
a The concentration of CPI-I’ was 230 nM.
b FRET efficiency is calculated by the equation FRET  1  (Fda/Fd) where
Fda is CPI-I’ fluorescence with FITC-IpgC and Fd is CPI-I’ fluorescence with
unlabeled IpgC.
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may stem from differences in the binding of the latter with
IpaB. SipC also binds to FITC-IpgC, although the affinity ap-
pears to be less than that seen between FITC-IpaC and unla-
beled IpgC (data not shown).
We recently reported that the difference between IpaC and
SipC was most likely related to effector functions located at the
C terminus of IpaC, since both proteins associate with IpaB,
SipB, and IpgC (27). However, sequence differences at the N
terminus of these proteins and the observation that SipC binds
with reduced affinity to IpaB (Table 5) and IpgC relative to
IpaC suggest that functional differences associated with the N
terminus of these proteins (chaperone binding and/or translo-
con formation) could account for the inability of sipC to re-
store invasiveness to S. flexneri SF621. To test this, IpaC-SipC
chimeras were generated and their ability to restore invasive-
ness to SF621 was determined. In all cases, when N-terminal
portions of IpaC are fused with C-terminal portions of SipC,
no invasiveness is restored to SF621 (data not shown). In
contrast, when the amino acids of SipC corresponding to
amino acids 19 to 62 of IpaC are fused with amino acids 63
to 363 of IpaC, SF621 invasiveness is restored to 90% (	15%;
n  3). Interestingly, when larger regions of the SipC N ter-
minus are used to replace the corresponding portion of IpaC
(e.g., SipC residues 1 to 189 replacing residues 19 to 170 of
IpaC), invasiveness is not restored to SF621 (data not shown).
These data suggest that in Shigella, IpaC and SipC function
may differ as a result of both effector function and transloca-
tion; however, at least part of the putative chaperone binding
site, corresponding to IpaC amino acids 50 to 80, is inter-
changeable. This is consistent with previous findings that co-
expression of sipC and its cognate Salmonella chaperone sicE
in SF621 is still incapable of restoring invasiveness.
DISCUSSION
Diarrheal diseases are among the most important global
public health problems, and S. flexneri is responsible for sig-
nificant morbidity and mortality for young children in devel-
oping regions of the world (15). IpaC mediates S. flexneri entry
into the cytoplasm of enterocytes, an essential step in the
pathogenesis of shigellosis (39). Understanding the mechanism
of S. flexneri invasion (both its uniqueness and its similarity to
other TTSS substrates) requires answering detailed questions
about the basic protein biochemistry of IpaC. Elucidation of
the requirements for secretion located at the N terminus of
IpaC is the first step toward finding a common denominator in
the secretion mechanism of members of the Ipa protein family
along with providing new information relevant to the export of
TTSS substrates from diverse gram-negative bacteria that com-
municate with a wide variety of eukaryotic cells (18). A unique
feature of IpaC and the related Salmonella protein SipC, how-
ever, is the fact that they are the only known TTSS substrates
that simultaneously (i) are part of a conduit or translocon
through the host cytoplasmic membrane used to transport
other proteins into the host cell and (ii) possess effector activ-
ities that subvert the host cell actin cytoskeleton (5, 17, 18). In
other systems, including that of Salmonella, additional special-
ized effector proteins (not part of the pore complex) must be
injected directly into the host cytoplasm to subvert host signal-
ing mechanisms (18).
IpaC secretion by S. flexneri requires amino acid sequences
located at its immediate N terminus; however, no specific con-
sensus sequence can be proposed. Instead, the accumulated
data seem to indicate that there is a physical or structural
determinant that directs effector protein export. This is in
agreement with data on TTSS substrates in Yersinia, where a
poly(I-S) sequence is sufficient for directing Yop secretion (20)
and changing the overall hydrophobicity of the region can have
an effect on secretion (21). Unlike in Yersinia, however, re-
placement of the IpaC secretion signal with poly(I-S) is not
sufficient to direct its export from S. flexneri SF621. On the
other hand, when the first five amino acids of IpaC are changed
from highly polar residues to Ala, secretion is drastically re-
duced even though individual Ala substitutions have no effect.
Furthermore, when the N-terminal MLQKQFC sequence of
the IpaC derivative generated from pWPsf4c6-20 was
changed to MHQIQTC to place a charged residue at the sec-
ond position, a hydrophobic residue at the fourth position, and
a Thr in place of Phe, secretion is fully restored. As in Yersinia,
no specific secretion signal can be identified for IpaC in Shi-
gella, but physical and/or structural features appear to have a
major role in targeting this protein for type III secretion. Fur-
ther study of the IpaC secretion signal will require a more
thorough analysis of the structural and biophysical nature of
the peptide(s) present at the immediate N terminus.
Downstream from the IpaC secretion signal is a region re-
quired for IpaC’s ability to direct invasion and contact hemo-
lysis but which is not required for IpaC secretion via the Shi-
gella TTSS apparatus. Amino acids 50 to 80 appear to
contribute substantially to the tight association of IpaC to both
the cytoplasmic chaperone IpgC and the other Shigella trans-
locon component IpaB. By fluorescence polarization analysis,
the probable dissociation constants for IpaB-IpaC, IpgC-IpaC,
and IpgC-IpaB interactions are in the low nanomolar range,
which is consistent with that observed for the SycE-YopE in-
teraction in Yersinia (9); however, the location of the SycE
binding region on YopE appears to be nearer to the N termi-
nus, beginning at amino acid 15 (4), than is the IpgC binding
region on IpaC. Page and colleagues assigned IpgC binding to
amino acids 58 to 72 of IpaB and to amino acids 73 to 122 of
IpaC by using yeast two-hybrid analysis (28). The latter IpgC
binding site differs slightly from what is reported here; how-
ever, the different biophysical methods used here clearly indi-
cate that IpgC occurs very near amino acid 50 of IpaC, with












FITC-IpaC IpaB 19.0 	 5.1
SipB 23.1 	 5.3
FITC-SipC IpaB 77.2 	 15.6
SipB 15.5 	 2.5
a The values given are in millipolarization (mP) units. mP is the change in
polarization as a function of IpaB/SipB concentration. The fluorescent protein
was used at 25 nM, indicating that the values given are not true dissociation
constants.
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IpaB probably binding at sequences downstream from, but
possibly overlapping, this position. Also, deletions that include
amino acids 51 to 55 of IpaC abruptly eliminate IpaC invasion
and hemolysis functions, suggesting that a region critical for
IpaC activity butts up against amino acid 50.
Page also suggested that deletion of a segment of IpaC that
includes the chaperone binding region (amino acids 56 to 143)
may reduce its stability in S. flexneri but not in E. coli (28). We
did not observe reduced levels of IpaC in the cytoplasm of
SF621 for mutations within the region encompassed by amino
acids 50 to 100; however, deletion of amino acids 41 to 100 and
21 to 100 did result in slightly less IpaC being detected by
ELISA in S. flexneri cell extracts. This could be due to insta-
bility, but the data presented here don’t appear to be consistent
with chaperone binding being required for IpaC stability in the
Shigella cytoplasm. In other work, we have found that deletion
of an internal portion of IpaC that includes the central hydro-
phobic domain (amino acids 63 to 170) results in relatively low
levels of the protein (IpaC63-170) in the S. flexneri cytoplasm
(unpublished observation) despite the fact that the protein is
very efficiently secreted (30). In contrast, IpaC63-170 is quite
stable when made in E. coli, which is consistent with the data
reported for the 56-143 IpaC deletion mutant by Page (28). In
examining the protein generated in E. coli, we have found that
removal of the IpaC hydrophobic region results in a significant
loss of tertiary structure (unpublished data), which could pro-
vide a signal for the destruction of IpaC in the S. flexneri
cytoplasm.
Interestingly, the interaction of an IpaC N-terminal frag-
ment with IpaB and IpgC is competitive, which is consistent
with the role of IpgC in preventing the premature association
of IpaC and IpaB in the Shigella cytoplasm. Based on fluores-
cence emission and quenching data, it appears that IpgC binds
near amino acid 50, which shields the fluorescent probe on
FM-IpaCCys from quenching agents in the surrounding solvent,
while IpaB may bind further downstream and is therefore less
efficient at protecting FM-IpaCCys fluorescence from acryl-
amide quenching (Fig. 3). Since the binding regions on IpaC
recognized by IpgC and IpaB appear to overlap but are not
identical, simultaneous binding of the proteins is precluded
without requiring identical binding sequences. Because IpgC
appears to bind more closely to amino acid 50 than does IpaB
and deletions that extend downstream of amino acid 50 pre-
vent IpaC function in S. flexneri, chaperone binding appears to
be required for proper IpaC function. The observation that
SipC sequences up to the equivalent of IpaC residue 62 can
replace the corresponding sequence in IpaC suggests that
chaperone binding between Shigella and Salmonella is inter-
changeable; however, important sequences downstream of the
chaperone binding site (required for proper translocon forma-
tion with IpaB) are not readily swapped without loss of func-
tion (data not shown).
This study represents the most detailed description of the
functional importance of the N terminus of IpaC to date. An
important aspect of the data presented here is the apparent
close relationship between disruption of the chaperone and
IpaB binding regions of IpaC and the loss of both invasion
function and contact-mediated hemolysis activity. The inability
to separate these activities by introducing mutations within the
N-terminal quarter of IpaC suggests that these mutations
cause defects in the presentation of the protein to target cells
(whether enterocytes or erythrocytes) in the context of IpaB.
The ability to lyse red blood cells is probably a function of IpaC
and IpaB association with and disruption of phospholipid
membranes. Such a function would not require specific inter-
action with host cell signaling molecules such as Cdc42. Im-
proper translocation could result in incorrect placement of the
protein in the host cell membrane in association with IpaB.
This would prevent IpaC from carrying out its effector activity
and prevent the IpaB/IpaC complex from disrupting the mem-
brane as needed for contact-mediated hemolysis. Therefore,
the N terminus of IpaC serves primarily in the proper secre-
tion, transport, and presentation of the protein to target cells,
while the IpaC effector activity resides within the C-terminal
half of the protein (unpublished data).
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